Eric Ostertag

2022

In 2022, Eric Ostertag earned a total compensation of $1.3M as Former Executive Chairman and former Chief Executive Officer at Poseida Therapeutics, a 79% decrease compared to previous year.

Compensation breakdown

Option Awards$429,972
Salary$448,313
Stock Awards$425,125
Other$12,710
Total$1,316,120

Ostertag received $448.3K in salary, accounting for 34% of the total pay in 2022.

Ostertag also received $430K in option awards, $425.1K in stock awards and $12.7K in other compensation.

Rankings

In 2022, Eric Ostertag's compensation ranked 2,492nd out of 5,683 executives tracked by ExecPay. In other words, Ostertag earned more than 56.1% of executives.

ClassificationRankingPercentile
All
2,492
out of 5,683
56th
Division
Manufacturing
1,367
out of 3,091
56th
Major group
Chemicals And Allied Products
617
out of 1,406
56th
Industry group
Drugs
571
out of 1,307
56th
Industry
Biological Products, Except Diagnostic Substances
144
out of 295
51st
Source: SEC filing on April 26, 2023.

Ostertag's colleagues

We found three more compensation records of executives who worked with Eric Ostertag at Poseida Therapeutics in 2022.

2022

Mark Gergen

Poseida Therapeutics

Chief Executive Officer

2022

Brent Warner

Poseida Therapeutics

President, Gene Therapy

2022

Harry Leonhardt

Poseida Therapeutics

General Counsel

News

You may also like